MedTrace Logo

Molecular MRI of the Fibrotic Heart

NCT02012725 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2018-01-23

No results posted yet for this study

Summary

This study is a feasibility study to validate magnetizatin transfer (MT)-weighted balanced steady state free precession (bSSFP) cine cardiac magnetic resonance (CMR) against current clinical gold standard diagnostics, and to determine the applicability of MT-weighted bSSFP cine CMR for diagnosis of fibrotic remodeling in chronic kidney disease (CKD5) patients. Participants will not receive a study drug or placebo and will not be randomized. A total of 250 participants will be enrolled into this study.

Conditions

Interventions

DRUG

Arm 1 MRI with gadolinium

Healthy volunteers will not receive gadolinium

Sponsors & Collaborators

  • Moriel Vandsburger

    lead OTHER

Principal Investigators

  • Moriel Vandsburger, PhD · University of Kentucky, Department of Physiology

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-05-01
Completion
2017-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02012725 on ClinicalTrials.gov